GMBVX Mutual Fund

NAV$24.91

Fund Essentials - as of Feb 28, 2026

Net Assets
-
Expense Ratio
0.76%
Dividend Yield (Current)
0.20%
Holdings
43
Inception Date
Apr 29, 2025
Fund Family
GMO
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Semi-Annually

Performance

YTD+14.48%

Asset Allocation

Stocks: 97.16%
Cash: 0.04%
Other: 2.80%

Top Holdings

View All →
TickerNameWeight
PSMTPricesmart Inc4.24%
NYTNew York Times Co4.22%
BCPCBalchem Cp4.10%
GMEDGlobus Medical, Inc. (class A)4.07%
ARMKAramark Holdings3.72%
Top 10 Concentration: 38.06%Report Date: Feb 28, 2026
Download all 43 holdings for GMBVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.20%
Frequency
Semi-Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

GMBVX Mutual Fund Overview

GMBVX Mutual Fund (GMO Small Cap Quality Fund Class R6) is managed by GMO. GMBVX expense ratio is 0.76%, holding 43 positions across sectors including Industrials, Information Technology, Materials. Inception date: 2025-04-29.

GMBVX performance shows a YTD return of 14.48%.. GMBVX dividend yield stands at 0.20%, paid semi-annually.

GMBVX top holdings include Pricesmart Inc (4.2%), New York Times Co (4.2%), Balchem Cp (4.1%), Globus Medical, Inc. (class A) (4.1%), Aramark Holdings (3.7%). View all GMBVX holdings, sector breakdown, or dividend history.

GMBVX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GMBVX alternatives are available via the screener, along with tax-loss harvesting opportunities.